Rocket Lab USA, Inc. (NASDAQ:RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1... Rocket Lab USA, Inc. (RKLB) reported Q1 EPS of ($0.06), $0.02 worse ...

Rocket Lab is poised for significant growth with 20+ launches in 2025, including the highly anticipated Neutron rocket, a cost-effective Falcon 9 competitor. Despite a 35% stock retracement ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00.

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...

Rocket Lab USA, Inc. (RKLB) stock has reached an all-time high, soaring to $21.37, marking a significant milestone for the ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Browse 770+ rocket ship launch pad stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art.

Rocket Lab USA, Inc. (Nasdaq: RKLB) today announced it has signed a deal with Japanese Earth imaging company Synspective to launch... Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company” ...

Rocket Lab USA, Inc. (RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with... Rocket Lab USA, Inc. (RKLB) reported Q1 EPS of ($0.06), $0.02 worse ...

In response, Rocket Lab stock soared by more than 7% in the opening minutes of trading Friday before retreating to about a ...